Go Pro
NYSE:GMED

Globus Medical Q2 2026 Earnings Report

Globus Medical logo
$80.78 +2.22 (+2.83%)
As of 03:35 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Globus Medical EPS Results

Actual EPS
N/A
Consensus EPS
$1.12
Beat/Miss
N/A
One Year Ago EPS
N/A

Globus Medical Revenue Results

Actual Revenue
N/A
Expected Revenue
$782.82 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Globus Medical Announcement Details

Quarter
Q2 2026
Time
After Market Closes
Conference Call Date
Thursday, August 6, 2026
Conference Call Time
4:30PM ET

Conference Call Resources

Globus Medical Earnings Headlines

URGENT Dollar Reset Warning for Monday
A 50-year U.S.-Saudi arrangement established under Henry Kissinger - one credited with anchoring the dollar in global trade - is reportedly over. Analyst Garrett Goggin, CFA, CMT believes what follows could be the most significant dollar reset in modern history. Goggin has recorded an emergency briefing outlining what investors should consider doing now - including one asset he believes is positioned to climb sharply, similar to how it performed during the currency turbulence of the 1970s.tc pixel
See More Globus Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Globus Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Globus Medical and other key companies, straight to your email.

About Globus Medical

Globus Medical (NYSE:GMED) (NYSE:GMED) is a leading medical device company specializing in musculoskeletal solutions for spine and orthopaedic applications. Founded in 2003 by David C. Paul and headquartered in Audubon, Pennsylvania, the company develops, manufactures and markets implantable devices and surgical instruments designed to treat spinal disorders and promote bone healing. Its product portfolio encompasses solutions for minimally invasive and open surgical procedures, including interbody fusion devices, pedicle screw systems, and biologics used to enhance fusion outcomes.

In addition to its core spine business, Globus Medical has expanded into robotics and navigation systems to support precision and efficiency in the operating room. The ExcelsiusGPS® robotic guidance system, for example, integrates real-time imaging with robotic arm technology to enable surgeons to perform complex procedures with greater accuracy. The company also offers an array of trauma and orthopaedic solutions, such as bone graft substitutes and joint reconstruction implants, to address a broad spectrum of musculoskeletal conditions.

Globus Medical serves surgeons and patients across North America, Europe, Asia, Latin America and the Middle East through a combination of direct sales and distribution partnerships. Under the leadership of founder and Executive Chairman David C. Paul and President and Chief Executive Officer Glenn J. Shapiro, the company has built a global commercial infrastructure and invested in research and development to drive innovation. Its commitment to surgical education and customer support further reinforces its position in the competitive medical device landscape.

View Globus Medical Profile